BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 26779510)

  • 1. Therapeutic Neovascularization for Refractory Angina-Are We Any Closer?
    Alkhunaizi FA; Burkhoff D
    J Soc Cardiovasc Angiogr Interv; 2023; 2(1):. PubMed ID: 36875178
    [No Abstract]   [Full Text] [Related]  

  • 2. PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era.
    Chapman MJ; Stock JK; Ginsberg HN;
    Curr Opin Lipidol; 2015 Dec; 26(6):511-20. PubMed ID: 26780005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a): the underutilized risk factor for cardiovascular disease.
    Khan TZ; Bornstein SR; Barbir M
    Glob Cardiol Sci Pract; 2019 Sep; 2019(2):e201911. PubMed ID: 31799286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apheresis as novel treatment for refractory angina with raised lipoprotein(a): a randomized controlled cross-over trial.
    Khan TZ; Hsu LY; Arai AE; Rhodes S; Pottle A; Wage R; Banya W; Gatehouse PD; Giri S; Collins P; Pennell DJ; Barbir M
    Eur Heart J; 2017 May; 38(20):1561-1569. PubMed ID: 28453721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a), cardiovascular disease, and contemporary management.
    Jacobson TA
    Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of raised lipoprotein(a) in patients with refractory angina.
    Khan TZ; Rhodes S; Pottle A; Banya W; Smith R; Kabir T; Ilsley C; Pennell DJ; Barbir M
    Glob Cardiol Sci Pract; 2015; 2015(2):28. PubMed ID: 26779510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial.
    Khan TZ; Pottle A; Pennell DJ; Barbir MS
    Atheroscler Suppl; 2015 May; 18():103-8. PubMed ID: 25936312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina.
    Khan TZ; Pottle A; Pennell DJ; Barbir MS
    Glob Cardiol Sci Pract; 2014; 2014(1):3-12. PubMed ID: 25054114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a).
    Khan TZ; Hartley A; Haskard D; Caga-Anan M; Pennell DJ; Collins P; Barbir M; Khamis R
    Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33477712
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
    Gupta R; Vasisht S; Bahl VK; Wasir HS
    Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of extended-release niacin with laropiprant in high-risk patients.
    ; Landray MJ; Haynes R; Hopewell JC; Parish S; Aung T; Tomson J; Wallendszus K; Craig M; Jiang L; Collins R; Armitage J
    N Engl J Med; 2014 Jul; 371(3):203-12. PubMed ID: 25014686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.
    Raal FJ; Giugliano RP; Sabatine MS; Koren MJ; Langslet G; Bays H; Blom D; Eriksson M; Dent R; Wasserman SM; Huang F; Xue A; Albizem M; Scott R; Stein EA
    J Am Coll Cardiol; 2014 Apr; 63(13):1278-1288. PubMed ID: 24509273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of refractory angina pectoris.
    Manchanda A; Aggarwal A; Aggarwal N; Soran O
    Cardiol J; 2011; 18(4):343-51. PubMed ID: 21769814
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.